Primer: Jiangsu Hengrui Pharmaceuticals (1276 HK) - Aug 2026
Transition to Innovation Powerhouse: Jiangsu Hengrui is successfully transitioning from a generics-focused company to an innovation-driven...
95 Views
𝛼SK or SearchENTITY
Jiangsu Hengrui Pharmaceuticals (1276 HK)
Jiangsu Hengrui Pharmaceuticals (1276 HK)
316
Analysis
Health Care • China
Jiangsu Hengrui Pharmaceuticals is a global biopharmaceutical company engaged in the research, development, manufacturing, and commercialization of innovative and high-quality drugs. The company focuses on therapeutic areas including oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. It was founded in 1970 and is headquartered in Lianyungang, Jiangsu, China.
morex